Longitudinal assessment

Ended Definitive Contract Awarded Last action

Contract number
HHSD200201691935C
Awardee
Awarding agency
Obligated
$521,014

Award facts

Contract value 100% obligated
$521,014.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Available for Competition · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Atlanta, GA 30329, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope 2 $0
Supplemental Agreement for work within scope 1 $0
Original award $521,014

About this award

The U.S. Centers for Disease Control and Prevention (CDC) awarded a Firm Fixed Price Definitive Contract worth $521,014.00 to Synthetic Biologics, Inc. for a LONGITUDINAL ASSESSMENT project. The contract has an ultimate completion date of December 31, 2017 and was awarded on September 14, 2016. The contract was not set aside for any specific business type. The contract is for work to be performed in Atlanta, Georgia.

Quick answers

Who was awarded contract HHSD200201691935C?

HHSD200201691935C was awarded to Theriva Biologics, Inc. by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 14, 2016.

How much is contract HHSD200201691935C worth?

The government has obligated $521,014 on HHSD200201691935C.

Was contract HHSD200201691935C competed?

The extent of competition for HHSD200201691935C was not available for competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award